Satsuma Pharmaceuticals Buy Hold or Sell Recommendation
| STSADelisted Stock | USD 1.10 0.01 0.90% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Satsuma Pharmaceuticals is 'Not Rated'. Macroaxis provides Satsuma Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding STSA positions.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. In addition, we conduct extensive research on individual companies such as Satsuma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Satsuma Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Satsuma |
Execute Satsuma Pharmaceuticals Buy or Sell Advice
The Satsuma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Satsuma Pharmaceuticals. Macroaxis does not own or have any residual interests in Satsuma Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Satsuma Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Satsuma Pharmaceuticals Trading Alerts and Improvement Suggestions
| Satsuma Pharmaceuticals is not yet fully synchronised with the market data | |
| Satsuma Pharmaceuticals may become a speculative penny stock | |
| Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors |
Satsuma Pharmaceuticals Returns Distribution Density
The distribution of Satsuma Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Satsuma Pharmaceuticals' future price movements. The chart of the probability distribution of Satsuma Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Satsuma Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Satsuma Pharmaceuticals returns is essential to provide solid investment advice for Satsuma Pharmaceuticals.
| Mean Return | 0.51 | Value At Risk | -7.79 | Potential Upside | 5.71 | Standard Deviation | 8.57 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Satsuma Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition pursuant to a tender of shares in a change of control transaction by Thomas ONeil of Satsuma Pharmaceuticals [view details]
Satsuma Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Satsuma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Satsuma Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Satsuma Pharmaceuticals? Buying financial instruments such as Satsuma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Satsuma Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Latest Losers Thematic Idea Now
Latest Losers
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 206 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |